Serum Institute of India, the largest vaccine manufacturer in the world, is a partner in the Oxford vaccine project and has been chosen by Oxford and AstraZeneca to manufacture the vaccine once it gets ready."The trials have shown promising results and we are extremely happy about it.
As soon as they grant us permission, we will begin with the trials for the vaccine in India," Serum Institute's Chief Executive Officer Adar Poonawalla said."In addition, we will soon start manufacturing the vaccine in large volumes."Earlier, Pune-based Serum Institute of India had said that it will start manufacturing the vaccine even before the final nod so as to be ready with sizeable volumes once the vaccine gets all permissions.The Oxford vaccine prompted.